Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
ProPhase Labs, Inc. LTRN Lantern Pharma Inc. 13G/A 5.8% 2y
Venrock Healthcare Capital Partners III, L.P. TSHA Taysha Gene Therapies, Inc. 13G/A 5.6% 2y
Arie Belldegrun, M.D. ALLO Allogene Therapeutics, Inc. 13G/A 5.8% 2y
Deep Track Capital, LP EDIT Editas Medicine, Inc. 13G/A 6.7% 2y
BIOTECHNOLOGY VALUE FUND L P ACRS Aclaris Therapeutics, Inc. 13G/A 0% 2y
Westchester Capital Management, LLC AILE iLearningEngines, Inc. Common Stock 13G 9.69% 2y
ARMISTICE CAPITAL, LLC MBRX Moleculin Biotech, Inc. 13G 9.99% 2y
Ionic Ventures, LLC GROM Grom Social Enterprises Inc. Common Stock 13G/A 7.8% 2y
Cormorant Asset Management, LP ALPN Alpine Immune Sciences, Inc. Common Stock 13G/A 4.39% 2y
Venrock Healthcare Capital Partners II, L.P. INZY Inozyme Pharma, Inc. Common Stock 13G/A 0% 2y
Nikolaos Vlahos HNST Honest Company, Inc. 13G 5.4% 2y
Portolan Capital Management, LLC PRCH Porch Group, Inc. 13G/A 3.24% 2y
ALLIANCEBERNSTEIN L.P. ACIW Aci Worldwide, Inc. 13G/A 4.3% 2y
K2 HealthVentures Equity Trust LLC ELEV Elevation Oncology, Inc. Common stock 13G/A 4% 2y
ARMISTICE CAPITAL, LLC LLAP Terran Orbital Corporation 13G 8.17% 2y
T. Rowe Price Investment Management, Inc. NSSC Napco Security Technologies, Inc 13G 5.7% 2y
TENOR CAPITAL MANAGEMENT Co., L.P. LFLY Leafly Holdings, Inc. Common Stock 13G/A 0.7% 2y
GENERATION INVESTMENT MANAGEMENT LLP TYGO Tigo Energy, Inc. 13G/A 13.09% 2y
Fourthstone LLC BCAL California BanCorp \ CA 13G/A 8.13% 2y
FIR TREE CAPITAL MANAGEMENT LP IRRX Integrated Rail and Resources Acquisition Corp. 13G 6.11% 2y
Blue Owl Capital Holdings LP CGEM Cullinan Therapeutics, Inc. 13G 7.99% 2y
Select Equity Group, L.P. TTC Toro Co 13G/A 5.4% 2y
TANG CAPITAL MANAGEMENT, LLC BLPH Bellerophon Therapeutics, Inc. 13G/A 0% 2y
METEORA CAPITAL, LLC PHYT Pyrophyte Acquisition Corp. 13G 5.04% 2y
Conversant Capital LLC YELL Yellow Corporation Common Stock 13G/A 5% 2y
TIGER GLOBAL MANAGEMENT LLC ZKH ZKH Group Ltd 13G 6.5% 2y
272 Capital LP PAAI Paradium.AI, Inc. 13G/A 0% 2y
Paul L Berns NMRA Neumora Therapeutics, Inc. 13G 5.2% 2y
M3 Funds, LLC NECB NorthEast Community Bancorp, Inc. 13G/A 2.98% 2y
Radcliffe Capital Management, L.P. WQGA World Quantum Growth Acquisition Corp. 13G/A 0% 2y
Deep Track Capital, LP TERN Terns Pharmaceuticals, Inc. 13G/A 9.87% 2y
Sourcerock Group LLC TALO Talos Energy Inc. 13G 6% 2y
Sonali Paul GMED Globus Medical Inc 13G/A 16.24% 2y
ARMISTICE CAPITAL, LLC FRPT Freshpet, Inc. 13G/A 1.67% 2y
Walleye Capital LLC BBLG Bone Biologics Corp 13G/A 0% 2y
Point72 Asset Management, L.P. PAGS PagSeguro Digital Ltd. 13G/A 5.6% 2y
PERCEPTIVE ADVISORS LLC AMLX Amylyx Pharmaceuticals, Inc. 13G/A 2.8% 2y
First Trust Capital Management L.P. BAYA Bayview Acquisition Corp 13G 7.65% 2y
First Trust Capital Management L.P. CHEA Chenghe Acquisition Co. Class A Ordinary Share 13G 9.86% 2y
Cormorant Asset Management, LP CABA Cabaletta Bio, Inc. 13G/A 0% 2y
Venrock Healthcare Capital Partners II, L.P. SVRA Savara Inc 13G/A 2.6% 2y
TIGER GLOBAL MANAGEMENT LLC OKLO Oklo Inc. 13G/A 9.99% 2y
ALLIANCEBERNSTEIN L.P. VBNK VersaBank 13G 6.2% 2y
Edward Jay Kreps CFLT Confluent, Inc. Class A Common Stock 13G/A 8.2% 2y
AMERIPRISE FINANCIAL INC ALT Altimmune, Inc. 13G 7.79% 2y
683 Capital Management, LLC INSE Inspired Entertainment, Inc. 13G/A 6.9% 2y
683 Capital Management, LLC ARYE ARYA Sciences Acquisition Corp V Class A Ordinary Shares 13G/A 0% 2y
Ancient Art, L.P. SEMR SEMrush Holdings, Inc. 13G/A 2.3% 2y
ARMISTICE CAPITAL, LLC AUTL Autolus Therapeutics plc 13G/A 2.21% 2y
Walleye Capital LLC KCGI Kensington Capital Acquisition Corp. V 13G 6.52% 2y